Adviser
H.C. Wainwright & Co..
Financial adviser on 4 live deals, from 11 Mar 2022 to 14 Jul 2026.
04Live deals
05Other advisers
Deals
| Date | Deal | Stage | Role | Sector |
|---|---|---|---|---|
| 14 Jul 2026 | Ligand Pharmaceuticals Incorporated / XOMA Royalty | Closed |
| Healthcare |
| 14 Jul 2026 | Ligand Pharmaceuticals Incorporated / XOMA Royalty Corporation | Closed |
| Healthcare |
| 26 Aug 2024 | Insud Pharma, S.L. / Agile Therapeutics, Inc. | Closed |
| Healthcare |
| 11 Mar 2022 | Novan, Inc. / EPI Health, LLC | Closed |
| Healthcare |
By year, sector and stage
| 2026 | 2 |
|---|---|
| 2024 | 1 |
| 2022 | 1 |
| Healthcare | 4 |
|---|
| Closed | 4 |
|---|
Other advisers on the same deals
| Adviser | Shared deals | Across the table | Alongside |
|---|---|---|---|
| Gibson, Dunn & Crutcher LLP | 2 | 0 | 2 |
| Leerink Partners | 2 | 0 | 2 |
| RC Law LLP | 1 | 1 | 0 |
| Morgan, Lewis & Bockius LLP | 1 | 0 | 1 |
| Wainwright | 1 | 0 | 1 |